Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
China
· Delayed Price · Currency is CNY 16.92
+0.13 (0.77%)
Mar 10, 2026, 2:24 PM CST
SHA:600129 Revenue
Chongqing Taiji Industry(Group) Co.,Ltd had revenue of 2.43B CNY in the quarter ending September 30, 2025, a decrease of -7.13%. This brings the company's revenue in the last twelve months to 10.04B, down -27.63% year-over-year. In the year 2024, Chongqing Taiji Industry(Group) Co.,Ltd had annual revenue of 12.39B, down -20.72%.
Revenue (ttm)
10.04B
Revenue Growth
-27.63%
P/S Ratio
0.92
Revenue / Employee
838.69K
Employees
11,971
Market Cap
9.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.39B | -3.24B | -20.72% |
| Dec 31, 2023 | 15.62B | 1.50B | 10.58% |
| Dec 31, 2022 | 14.13B | 1.98B | 16.28% |
| Dec 31, 2021 | 12.15B | 941.63M | 8.40% |
| Dec 31, 2020 | 11.21B | -435.28M | -3.74% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Lukang Pharmaceutical | 6.19B |
| Jiangsu Yahong Meditech | 277.12M |
| North China Pharmaceutical Company.Ltd | 9.79B |
| KPC Pharmaceuticals,Inc. | 6.58B |
| Changzhou Qianhong Biopharma CO.,LTD | 1.53B |
| Zhejiang Xianju Pharmaceutical | 3.59B |
| Shenzhen Neptunus Bioengineering | 27.28B |
| Harbin Pharmaceutical Group | 15.94B |